Human papillomavirus-related carcinoma
Clinical trials for Human papillomavirus-related carcinoma explained in plain language.
Never miss a new study
Get alerted when new Human papillomavirus-related carcinoma trials appear
Sign up with your email to follow new studies for Human papillomavirus-related carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to block HPV cancers missed by current shots
Vaccine Recruiting nowThis early-stage trial tests a new vaccine called RG1-VLP in 18 healthy women aged 18-60. The vaccine targets HPV types not covered by existing vaccines like Gardasil 9. Researchers will check if it is safe and triggers a strong immune response. If it works, it could help prevent…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Vaccine
Last updated Sep 11, 2026 00:00 UTC
-
Can pharmacy training boost HPV shots and prevent future cancers?
Prevention Recruiting nowThis study looks at whether training pharmacy staff to better communicate about and manage the HPV vaccine can increase vaccination rates in children ages 9-17. About 1,900 participants, including pharmacy staff and parents, will be involved. The goal is to make it easier for fam…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA
Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Could a simple education push prevent 400,000 cancers?
Prevention Recruiting nowThis trial tests whether a program called TweenVax, which provides education and training to clinics, providers, and parents, can increase HPV vaccination rates among adolescents aged 9 to 12. Researchers will compare clinics using TweenVax to those using standard vaccination pro…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA
Sponsor: Emory University • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC